![](https://investorshub.advfn.com/uicon/182624.png?cb=1494591724)
Wednesday, May 10, 2017 12:20:35 PM
Dave,
Thank you for your interest in Nutra Pharma Corporation.
We have no way of knowing what will happen with the stock price. I can tell you that it’s only down now because of the toxic convertible debt that we took last year. We believe that once the conversions are completed and they’ve sold out of their stock (hopefully in the next several weeks) we should see some appreciation in the stock price.
I’ve recently conducted a few interviews on Rich TV-Live (#44 and #49:
Domestically, we are opening up channels for Nyloxin and expect growing sales throughout the next several quarters. We have also been working with our Pet Pain-Away distributor (DEG) as they have launched the TV and Internet campaign for the product. As for International distribution: we are working with several consultants and have begun the registration process in: Canada, China, Mexica, Spain and Israel. As I stated in my interviews – Nyloxin is already available to be sold in India. We have spoken with several potential new distributors and expect to see the first orders go out later this year.
Lastly, we hired Dr. Dale Vanderputten a few months ago as our new Chief Scientific Officer to take over the clinical development pipeline. His primary efforts are to move forward with RPI-78M under Orphan Designation for the treatment of Pediatric Multiple Sclerosis. We expect to announce the commencement of Phase II clinical trials shortly.
I hope that this information is helpful.
Best regards,
Rik
FEATURED Cannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA • Jul 29, 2024 9:07 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM
BNCM AND DELEX UNVEIL POST-MERGER MANAGEMENT PLANS • BNCM • Jul 29, 2024 9:00 AM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM